GISSI-Prevention Study

Italian doctors in the GISSI-Prevention Study had the same happy results when heart attack patients tried the Mediterranean diet, this time supplemented with omega-3 fatty acids. After three and a half years, the rates of nonfatal heart attacks, strokes, and deaths were down substantially. 

The Lyon and GISSI-Prevention studies are particularly noteworthy because their subjects already had heart disease severe enough to have caused heart attacks. If those approaches worked for already diseased men and women, think of what they can do for you ... 

Cambridge Heart Antioxidant Study DATATOR Deprenyl and Tocopherol Antioxidative Therapy of Rarkinsonism FMC, Finnish Mobile Clinic Health Examination Survey GISSI, Gruppo Italiano Studio Soprawivenza Infarto HOPE, Heart Outcome Prevention Evaluation HPFS, Health Professional Follow-up Study NHS, Nurses Health Study PPR Primary Prevention Project SPACE, Secondary Prevention with Antioxidants of Cardiovascular disease in End-stage renal disease VEAPS, Vitamin E Atherosclerosis Prevention Study VECAT Vitamin E Cataract Age-related maculopathy Trial. 

ACE, angiotensin converting enzyme ATBC, Alpha Tocopherol Beta Carotene Prevention Study CHAOS, Cambridge Heart Antioxidant Study GiSSi, GiSSI Prevenzione Triai HOPE, Heart Outcomes Prevention Evaluation Study HPS, Heart Protection Study CHD, Coronary Heart Disease CVD, cardiovascuiar disease Ml, myocardial infarction PUPA, polyunsatutated fatty acids. 

The ability of a-tocopherol supplementation to prevent cardiovascular events in different populations was tested in four larger prospective clinical trials The a-Tocopherol, yS-Carotene Cancer Prevention (ATBC) study, the Cambridge Heart Antioxidant Study (CHAOS), the Gruppo Italiano per lo studio della Sopravvivenza nell Infarto Miocar-dito (GISSI) trial, and the Heart Outcome Prevention Evaluation (HOPE) study. In addition, at least two smaller prospective clinical trials have been completed the Secondary Prevention with... 

---